"33369-31-2"@en . . . . . . . . . . . . . . . "Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983."@en . . . . " "@en . . . "5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid"@en . "Zomepiracum"@en . "withdrawn"@en . "Zomepirac"@en . "Zomepirac was indicated for the management of mild to severe pain."@en . . . . . . . . . . . . "Humans and other mammals"@en . . "James B. Doherty, Debra L. Allison, \"Process for the preparation of zomepirac and related compounds.\" U.S. Patent US4374997, issued January, 1978."@en . . " "@en . . . . . .